Skip header and navigation

Refine By

2 records – page 1 of 1.

A 10 year asthma programme in Finland: major change for the better.

https://arctichealth.org/en/permalink/ahliterature168103
Source
Thorax. 2006 Aug;61(8):663-70
Publication Type
Article
Date
Aug-2006
Author
T. Haahtela
L E Tuomisto
A. Pietinalho
T. Klaukka
M. Erhola
M. Kaila
M M Nieminen
E. Kontula
L A Laitinen
Author Affiliation
Skin and Allergy Hospital, Helsinki University Central Hospital, P O Box 160, FIN-00029 HUS, Finland. tari.haahtela@hus.fi
Source
Thorax. 2006 Aug;61(8):663-70
Date
Aug-2006
Language
English
Publication Type
Article
Keywords
Adult
Anti-Asthmatic Agents - therapeutic use
Asthma - economics - epidemiology - therapy
Child
Communication
Cost of Illness
Disabled Persons
Emergency Treatment - statistics & numerical data
Finland - epidemiology
Health Promotion - economics - organization & administration - trends
Hospitalization - statistics & numerical data
Humans
Incidence
Insurance, Disability - economics
Interprofessional Relations
National Health Programs - economics - trends
Pharmaceutical Services - standards
Primary Health Care
Program Evaluation
Smoking - epidemiology
Abstract
A National Asthma Programme was undertaken in Finland from 1994 to 2004 to improve asthma care and prevent an increase in costs. The main goal was to lessen the burden of asthma to individuals and society.
The action programme focused on implementation of new knowledge, especially for primary care. The main premise underpinning the campaign was that asthma is an inflammatory disease and requires anti-inflammatory treatment from the outset. The key for implementation was an effective network of asthma-responsible professionals and development of a post hoc evaluation strategy. In 1997 Finnish pharmacies were included in the Pharmacy Programme and in 2002 a Childhood Asthma mini-Programme was launched.
The incidence of asthma is still increasing, but the burden of asthma has decreased considerably. The number of hospital days has fallen by 54% from 110 000 in 1993 to 51 000 in 2003, 69% in relation to the number of asthmatics (n = 135 363 and 207 757, respectively), with the trend still downwards. In 1993, 7212 patients of working age (9% of 80 133 asthmatics) received a disability pension from the Social Insurance Institution compared with 1741 in 2003 (1.5% of 116 067 asthmatics). The absolute decrease was 76%, and 83% in relation to the number of asthmatics. The increase in the cost of asthma (compensation for disability, drugs, hospital care, and outpatient doctor visits) ended: in 1993 the costs were 218 million euro which had fallen to 213.5 million euro in 2003. Costs per patient per year have decreased 36% (from 1611 euro to 1031 euro).
It is possible to reduce the morbidity of asthma and its impact on individuals as well as on society. Improvements would have taken place without the programme, but not of this magnitude.
Notes
Cites: Eur Respir J. 1999 Aug;14(2):288-9410515403
Cites: BMJ. 1996 Mar 23;312(7033):762-68605467
Cites: Allergy. 2005 Mar;60(3):283-9215679712
Cites: N Engl J Med. 2005 Apr 14;352(15):1519-2815829533
Cites: BMJ. 2005 May 21;330(7501):1186-715849204
Cites: Thorax. 2005 Jul;60(7):545-815994260
Cites: Eur Respir J. 2000 Feb;15(2):235-710706483
Cites: Respir Med. 2000 Apr;94(4):299-32710845429
Cites: CMAJ. 1999 Nov 30;161(11 Suppl):S1-6110906907
Cites: Pediatr Allergy Immunol. 2000 Nov;11(4):236-4011110578
Cites: Eur Respir J. 2000 Nov;16(5):802-711153575
Cites: Am J Respir Crit Care Med. 2001 Aug 15;164(4):565-811520716
Cites: Thorax. 2001 Oct;56(10):806-1411562522
Cites: J Allergy Clin Immunol. 2001 Nov;108(5 Suppl):S147-33411707753
Cites: Eur Respir J. 2002 Aug;20(2):397-40212212973
Cites: Thorax. 2003 Feb;58 Suppl 1:i1-9412653493
Cites: Int J Tuberc Lung Dis. 2003 Jun;7(6):592-812797704
Cites: J Allergy Clin Immunol. 2004 Jul;114(1):40-715241342
Cites: Scand J Public Health. 2004;32(4):310-615370772
Cites: Am Rev Respir Dis. 1985 Apr;131(4):599-6063994155
Cites: N Engl J Med. 1991 Aug 8;325(6):388-922062329
Cites: N Engl J Med. 1994 Sep 15;331(11):700-58058076
Cites: Qual Health Care. 1994 Mar;3(1):45-5210136260
Cites: BMJ. 1996 Mar 23;312(7033):748-528605463
Cites: Eur Respir J. 2004 Nov;24(5):734-915516665
PubMed ID
16877690 View in PubMed
Less detail

Corticosteroid therapy and need for hospital care in wheezing preschool children.

https://arctichealth.org/en/permalink/ahliterature196128
Source
Eur J Clin Pharmacol. 2000 Nov;56(8):591-6
Publication Type
Article
Date
Nov-2000
Author
P. Csonka
J. Mertsola
T. Klaukka
M. Kaila
M R Ståhlberg
P. Ashorn
Author Affiliation
University of Tampere, Medical School, P.O. Box 607, FIN-33101 Tampere, Finland. peter.csonka@uta.fi
Source
Eur J Clin Pharmacol. 2000 Nov;56(8):591-6
Date
Nov-2000
Language
English
Publication Type
Article
Keywords
Adrenal Cortex Hormones - economics - therapeutic use
Anti-Asthmatic Agents - therapeutic use
Anti-Inflammatory Agents - economics - therapeutic use
Asthma - complications - drug therapy - epidemiology
Child
Child, Preschool
Emergency Service, Hospital
Female
Finland - epidemiology
Hospitalization
Humans
Incidence
Infant
Length of Stay
Male
Respiratory Sounds - etiology
Retrospective Studies
Treatment Outcome
Abstract
To study the frequency of corticosteroid therapy and the use of inpatient care for preschool children with wheezing in two regions in Finland.
The Finnish Social Insurance Institution database on refundable asthma medication indicated that 1.18% of children in Tampere and 2.37% in Turku used inhaled corticosteroids regularly. To clarify the difference, hospital records of 800 randomly chosen 0.5-6.9-year-old children who had been treated for wheezing in Tampere or Turku University Hospital during 1995-1996 were retrospectively analysed.
The incidences of wheezing-related emergency room (ER) index visits were 11.0 visits/year/1000 children both in Tampere and Turku. Oral corticosteroids were given to 2.5% versus 24.2% of children in ER and 10.6% versus 89.7% in hospital ward in Tampere and Turku, respectively. Hospitalisation rates were 44.8% in Tampere and 36.8% in Turku (95% confidence interval for the difference 1.2-14.8%). In both regions, children with prior inhaled corticosteroid therapy needed less inpatient care. Mean duration of hospitalisation was 3.4 days in Tampere and only 1.4 days in Turku. Recurrent visits in 6 months were more common in Tampere.
There were marked regional differences in the management of preschool children with wheezing. On a population level, frequent use of corticosteroid therapy was associated with reduced hospital admissions.
PubMed ID
11151750 View in PubMed
Less detail